Earnings Feed
Start Free
|4Jun 9, 12:32 PM ET

Downey Gregory 4

4 · Lexaria Bioscience Corp. · Filed Jun 9, 2021

Insider Transaction Report

Form 4
Period: 2021-05-07
Lexaria Bioscience Corp.LEXX
Downey Gregory
Chief Financial Officer
Transactions
  • Other

    Stock Options

    2021-05-07−8,000→ 17,000 total
    Exercise: $9.60From: 2020-04-23Exp: 2025-04-23→ Common Shares (8,000 underlying)
Holdings

  • Stock Options

    Exercise: $5.04From: 2021-04-15Exp: 2026-04-15→ Common Shares (4,000 underlying)
    12,000

  • Stock Options

    Exercise: $5.04From: 2023-04-15Exp: 2026-04-15→ Common Shares (4,000 underlying)
    20,000

  • common shares

    1,833

  • Stock Options

    Exercise: $5.04From: 2022-04-15Exp: 2026-04-15→ Common Shares (4,000 underlying)
    16,000

  • Stock Options

    Exercise: $5.31From: 2022-04-26Exp: 2026-04-26→ Common Shares (5,000 underlying)
    25,000

  • Stock Options

    Exercise: $9.60From: 2020-04-23Exp: 2025-04-23→ Common Shares (8,000 underlying)
    8,000
Footnotes (1)
  • [F1]Cancelled Options

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT